Urgent.News

What's breaking now, across thousands of outlets.

World

Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care

Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

We haven't written up this one. The Hindu has the full story — the link below goes straight to it.

Read the original at thehindu.com →

More in World

More from Thursday 29 October →